niacinamide has been researched along with Constipation in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Constipation: Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.
Excerpt | Relevance | Reference |
---|---|---|
"This phase Ib study evaluated the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of AMG 102, a fully human monoclonal antibody against hepatocyte growth factor/scatter factor (HGF/SF), in combination with bevacizumab or motesanib in patients with advanced solid tumors." | 2.75 | A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors. ( Anderson, A; Beaupre, DM; Deng, H; Leitch, IM; Oliner, KS; Park, DJ; Rosen, PJ; Shubhakar, P; Sweeney, CJ; Yee, LK; Zhu, M, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosen, PJ | 1 |
Sweeney, CJ | 1 |
Park, DJ | 1 |
Beaupre, DM | 1 |
Deng, H | 1 |
Leitch, IM | 1 |
Shubhakar, P | 1 |
Zhu, M | 1 |
Oliner, KS | 1 |
Anderson, A | 1 |
Yee, LK | 1 |
Astegiano, M | 1 |
Pellicano, R | 1 |
Terzi, E | 1 |
Simondi, D | 1 |
Rizzetto, M | 1 |
1 trial available for niacinamide and Constipation
Article | Year |
---|---|
A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2010 |
1 other study available for niacinamide and Constipation
Article | Year |
---|---|
Treatment of irritable bowel syndrome. A case control experience.
Topics: Abdominal Pain; Adult; Angelica; Antidepressive Agents, Second-Generation; Case-Control Studies; Chi | 2006 |